Erythromycin Market
According to Intent Market Research, the Erythromycin Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 6.3% to touch USD 0.9 billion by 2030. The Erythromycin Market is dominated by key players such as Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals, Bristol-Myers Squibb, Mylan N.V., Novartis International AG, Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie Inc., AstraZeneca, Hikma Pharmaceuticals, Zydus Cadila, Dr. Reddy?s Laboratories, Aurobindo Pharma, Lupin Pharmaceuticals Inc.